Tag: Prescription Drugs
Consensus Statement Issued for Low-Dose Oral Minoxidil for Hair Loss
Seventy-six items achieved consensus, including indications for LDOM versus topical minoxidil, dosing for adults and teens, contraindications
Adding Pembrolizumab Ups Survival in Stage III Undifferentiated Sarcoma
Benefit seen for stage III undifferentiated pleomorphic sarcoma or dedifferentiated or pleomorphic liposarcoma of the extremity and limb girdles
Barriers to Widespread Access to Cancer Medications Include Excessive Cost
Solutions to address inequity in drug distribution include sharing production secrets, international funding, cost-effective screening
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage
Risk increased with worsening CKD stage with denosumab versus bisphosphonates; highest risk seen for dialysis-dependent CKD, CKD-mineral and bone disorder
ACR: Inebilizumab Reduces Risk for Flares in IgG4-Related Disease
Flare-free, treatment-free complete remission and flare-free, glucocorticoid-free complete remission improved with inebilizumab
ACR: Colchicine No Benefit for Painful Knee Osteoarthritis
No significant improvements seen in knee pain, function, or size of synovial effusions versus placebo
Oral Infigratinib Seems Safe for Children With Achondroplasia
At dose of 125 mg/kg body weight, oral infigratinib results in increased annualized height velocity and z score
Beta Blockers May Cause Depressive Symptoms
Findings seen in patients following myocardial infarction
Gabapentinoid Use Tied to Higher Risk for Hip Fractures
Associations especially strong in patients who are frail or have chronic kidney disease
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
Reduction seen in recurrent nephrolithiasis events for those receiving SGLT-2 inhibitors versus GLP-1 RAs, DPP-4 inhibitors
